Synapse - Nabil Rizk

Results (139)

In patients with stage I lung adenocarcinoma, tumor budding is a significant prognostic factor for recurrence, independent of the IASLC/ATS/ERS classification, and correlates with a protumor immune microenvironment

Meeting Abstract

Kadota, K.; Yeh, Y. C.; Rizk, N. P.; Rusch, V. W.; Adusumilli, P. S.; Travis, W. D.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

High local control rates with postoperative radiation therapy in incompletely resected non-small cell lung cancer (NSCLC) patients

Meeting Abstract

Din, S. U.; Wu, A. J.; Gelblum, D. Y.; Foster, A.; Chaft, J. E.; Rizk, N. P.; Huang, J.; Rimner, A.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Esophageal cancer recurrence patterns and implications for surveillance

Journal Article

Lou, F.; Sima, C. S.; Adusumilli, P. S.; Bains, M. S.; Sarkaria, I. S.; Rusch, V. W.; Rizk, N. P.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤ 2 cm

Journal Article

Nitadori, J.; Bograd, A. J.; Morales, E. A.; Rizk, N. P.; Dunphy, M. P. S.; Sima, C. S.; Rusch, V. W.; Adusumilli, P. S.
Annals of Surgical Oncology (2013)

Fulltext@MSK | Save

Surgery for Esophageal Cancer. Goals of Resection and Optimizing Outcomes

Journal Article

Rizk, N.
Thoracic Surgery Clinics (2013)

Fulltext@MSK | Save

Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: A proposal to reclassify T1 lung adenocarcinoma

Journal Article

Nitadori, J. I.; Colovos, C.; Kadota, K.; Sima, C. S.; Sarkaria, I. S.; Rizk, N. P.; Rusch, V. W.; Travis, W. D.; Adusumilli, P. S.
Chest (2013)

Fulltext@MSK | Save

Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller

Journal Article

Nitadori, J. I.; Bograd, A. J.; Kadota, K.; Sima, C. S.; Rizk, N. P.; Morales, E. A.; Rusch, V. W.; Travis, W. D.; Adusumilli, P. S.
JNCI: Journal of the National Cancer Institute (2013)

Fulltext@MSK | Save

A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography

Journal Article

Farjah, F.; Lou, F.; Sima, C.; Rusch, V. W.; Rizk, N. P.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab

Journal Article

Hellmann, M. D.; Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
Cancer Chemotherapy and Pharmacology (2013)

Fulltext@MSK | Save

Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers

Journal Article

Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Paik, P. K.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save